|
Referenz |
Lieferant |
Beschreibung |
Einheit |
Preis exkl. MwSt. |
|
|
|
EPY0001338 |
European Pharmacopoeia |
Oseltamivir impurity A 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001339 |
European Pharmacopoeia |
Oseltamivir impurity B 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001340 |
European Pharmacopoeia |
Oseltamivir impurity C 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001341 |
European Pharmacopoeia |
Oseltamivir impurity H 30mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001342 |
European Pharmacopoeia |
Sucralose impurity B 0.5mg |
|
157.76 CHF
171.49 €
|
|
|
|
EPY0001344 |
European Pharmacopoeia |
Sucralose 550mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001345 |
European Pharmacopoeia |
Ondansetron impurity A (3RS)-3-[(dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001346 |
European Pharmacopoeia |
Ondansetron impurity G (3RS)-3-[(1H-imidazol-1-yl)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one(C-demethylondansetron) 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001347 |
European Pharmacopoeia |
Ginsenoside Rb1 30mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001348 |
European Pharmacopoeia |
Gagapentin impurity B (1-cyanocyclohexyl)acetic acid 20mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001349 |
European Pharmacopoeia |
Gabapentin impurity D [1-[(3-oxo-2-azaspiro[4.5]dec-2-yl)methyl]cyclohexyl]acetic acid 20mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001350 |
European Pharmacopoeia |
Phenobarbital impurity A (5RS)-5-ethyl-2,6-diimino-5-phenyltetrahydropyrimidin-4(1H)-one 15mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001351 |
European Pharmacopoeia |
Phenobarbital impurity B (5RS)-5-ethyl-6-imino-5-phenyldihydropyrimidine-2,4(1H,3H)-dione 15mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001352 |
European Pharmacopoeia |
Nicergoline for system suitability 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001353 |
European Pharmacopoeia |
Carbon monoxide - reference spectrum TBC |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001354 |
European Pharmacopoeia |
Betaxolol impurity C 2-[[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]methyl]oxirane 5mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001355 |
European Pharmacopoeia |
Prednisolone for system suitability 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001356 |
European Pharmacopoeia |
Nicergoline impurity D 20mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001357 |
European Pharmacopoeia |
Butyl parahydroxybenzoate impurity E 15mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001358 |
European Pharmacopoeia |
Glycopyrronium impurity N 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001359 |
European Pharmacopoeia |
Prednisolone for peak identification 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001360 |
European Pharmacopoeia |
Betaxolol for peak identification 15mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001361 |
European Pharmacopoeia |
Amphotericin B for microbiological assay 100mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001362 |
European Pharmacopoeia |
Nicergoline for peak identification 1mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001363 |
European Pharmacopoeia |
Gentamicin for peak identification *** 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001365 |
European Pharmacopoeia |
Etoposide for system suitability 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001366 |
European Pharmacopoeia |
Torasemide impurity E ethyl[[4-[(3-methylphenyl]amino]pyridin-3-yl]sulfonyl]carbamate 0.0006mg |
|
157.76 CHF
171.49 €
|
|
|
|
EPY0001367 |
European Pharmacopoeia |
Cefprozil for peak identification 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001368 |
European Pharmacopoeia |
Cefprozil impurity mixture 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001369 |
European Pharmacopoeia |
Macrogol 30 dipolyhydroxystearate TBC |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001370 |
European Pharmacopoeia |
Olanzapine 200mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001371 |
European Pharmacopoeia |
Cefprozil 120mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001372 |
European Pharmacopoeia |
Cefprozil impurity A CRS 20mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001373 |
European Pharmacopoeia |
Nicergoline 50mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001374 |
European Pharmacopoeia |
Racemic methyldopa 5mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001375 |
European Pharmacopoeia |
Ergocalciferol for system suitability 10mg |
|
148.24 CHF
161.14 €
|
|
|
|
EPY0001376 |
European Pharmacopoeia |
2-Methylpyrazine 100mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001377 |
European Pharmacopoeia |
Nitrofural for peak identification TBC |
|
157.76 CHF
171.49 €
|
|
|
|
EPY0001378 |
European Pharmacopoeia |
Naringin 20mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001379 |
European Pharmacopoeia |
Levonorgestrel impurity B 15mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001380 |
European Pharmacopoeia |
Olanzapine for system sitability 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001381 |
European Pharmacopoeia |
Glucosamine for system suitability 3mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001382 |
European Pharmacopoeia |
Levothyroxine for peak identification 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001383 |
European Pharmacopoeia |
Homatropine methylbromide for system suitability TBC |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001384 |
European Pharmacopoeia |
Fusidic acid impurity mixture 0.048mg |
|
157.76 CHF
171.49 €
|
|
|
|
EPY0001385 |
European Pharmacopoeia |
Angelica pubescent root TBC |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001386 |
European Pharmacopoeia |
Angelica dahuria root TBC |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001387 |
European Pharmacopoeia |
Candesartan for peak identification 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001388 |
European Pharmacopoeia |
Candesartan cilexetil 60mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0001389 |
European Pharmacopoeia |
Candesartan for system suitability 10mg |
|
152.32 CHF
165.57 €
|
|
